image
Protagenic Therapeutics, Inc. PTIX
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 0.618
-8.36 %
$ 2.76 M
Market Cap
-0.43
P/E
CASH FLOW STATEMENT
-3.7 M OPERATING CASH FLOW
-85.76%
Growth Rates
1Year -85.76%
3Years -40.03%
5Years -28.16%
7Years -18.33%
10Years -27.59%
4.78 M INVESTING CASH FLOW
199.03%
Growth Rates
1Year 199.03%
3Years 0.00%
5Years 35.50%
7Years 0.00%
10Years 77.95%
0 FINANCING CASH FLOW
0.00%
Growth Rates
1Year 0.00%
3Years 0.00%
5Years 0.00%
7Years 0.00%
10Years 0.00%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Protagenic Therapeutics, Inc.
image
Net Income -5 M
Depreciation & Amortization 28.2 K
Capital Expenditures -150 K
Stock-Based Compensation 667 K
Change in Working Capital -114 K
Others 629 K
Free Cash Flow -3.85 M

Cash Flow

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Jun-2015 Jun-2014 Jun-2013 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Jul-2005 Jul-2004 Jul-2003 Jul-2002 Jul-2001 Jul-2000 Jul-1999 Jul-1998 Jul-1997 Jul-1996 Jul-1995
OPERATING CASH FLOW
Net Income (5.0) (3.6) (4.5) (2.5) (1.8) (2.6) (2.3) (2.3) (0.5) (1.1) (1.0) (19.7) (29.4) (115.8) (4.1) 0.7 94.5 K (1.3) (7.9) (0.7) 0.1 1.1 (0.7) 0.6 (0.9) (0.5) (0.8)
Depreciation & Amortization 28.2 K 30 0.4 286 339 347 148 534 1 K 0.38 1.2 1.6 3.7 5.9 1.3 25 K 0 0 2.5 2.1 2.0 1.9 1.9 1.5 1.1 1.1 1.1
Deferred Income Tax 0 0 (0.4) (0.2) (0.3) 0 91.8 K 0.4 0 0 0 (1.5) 3.7 (2.3) (1.1) 0.2 0 0 0 0 (0.2) 0 0 0 0 0 0
Stock Based Compensation 0.7 0.9 1.5 1.7 0.8 1.1 0.9 0.5 479 0.3 604 1.1 0.9 1.3 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Operating Activities 0.7 0.2 0.3 0.2 0.1 0.2 99.8 K 0.1 7 K 46 K 107 4.8 19.4 116.1 0.4 0.4 0 0.5 10.8 0 0 0 0 0.2 0.1 (0.5) 20 K
Change in Working Capital (0.1) 0.5 (0.1) (0.4) 0.7 0.1 16.9 K 1.94 K 0.1 60 K 0.7 2.4 (1.2) (0.8) (2.0) (0.3) 50.5 K 0 (3.6) 1.0 (0.4) 0.5 (0.9) (2.8) (2.6) (0.3) (0.9)
Cash From Operations (3.7) (2.0) (2.8) (1.3) (0.5) (1.1) (1.4) (1.1) (0.4) (0.8) (0.3) (11.2) (3.0) 4.4 (5.2) 0.9 44 K (0.8) 1.9 2.3 1.5 3.5 0.3 (0.4) (2.2) (0.2) (0.6)
INVESTING CASH FLOW
Capital Expenditures (0.1) 1.8 K 0 0 0 0 0 0 1 K 1 K 0 41 K (0.7) (2.0) (0.3) 77 K 0 0 (1.5) (1.8) (3.8) (3.2) 81 K 65 K (2.9) (1.4) (1.3)
Other Items 4.9 1.6 (9.9) 0 0.2 1.0 (1.3) 0 0 0 15 K 0.7 3.0 19.8 (4.9) (0.1) 0 6.4 0 0 1.8 1.6 (1.7) (3.7) 1.4 0 0
Cash From Investing Activities 4.8 1.6 (9.9) 0 0.2 1.0 (1.3) 0 1 K 1 K 15 K 0.7 2.4 17.8 (5.2) (0.2) 0 6.4 (1.5) (1.8) (1.9) (1.7) (1.8) (3.7) (1.5) (1.4) (1.3)
FINANCING CASH FLOW
Common Stock Repurchased 0 0 0 0 0 0 0 0 0 0 100 9 K (0.9) (4.1) 0 0 0 0 0 0 20 K (1.0) 0 0 0 0 1.5
Total Debt Repaid 0 0 0 1.3 0.7 0 0 19 K 0.3 0.2 0 0 (1.8) (0.1) (0.6) (0.3) 14 K 0 0 (0.6) 0.5 0.8 0 3.9 (3.2) 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 0 0 0.9 (0.1) 0 0 0 8.5 0 0 31 K 0 (0.1) 1.4 (0.5) (0.2) 30 K 0 (0.3) 9 K 0 (1.8) 1.6 0 0 1.2 2.1
Cash From Financing Activities 0 0 12.6 1.2 0.7 0 0 4.3 0.3 0.2 31 K 9 K (2.8) (2.8) 17.5 (0.5) 44 K 0 (0.3) (0.6) 0.5 (2.0) 1.6 3.9 3.9 1.2 2.1
CHANGE IN CASH
Net Change In Cash 1.1 (0.3) (0.1) (0.1) 0.4 37.2 K (2.7) 3.1 39 K (0.6) (0.3) (10.6) (3.5) 19.3 7.1 0.2 0 4.4 90 K 5 K 16 K (0.1) 99 K (0.3) 0.2 (0.4) 0.2
FREE CASH FLOW
Free Cash Flow (3.9) (2.0) (2.8) (1.3) (0.5) (1.1) (1.4) (1.1) (0.4) (0.8) (0.3) (11.3) (3.7) 2.3 (5.5) 0.9 44 K (0.8) 0.4 0.6 (2.3) 0.3 0.2 (0.5) (5.1) (1.6) (1.9)